Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase.

Mollard LM, Chauveau A, Boyer-Perrard F, Douet-Guilbert N, Houot R, Quintin-Roué I, Couturier MA, Dagorne A, Malou M, Le Calloch R, Luycx O, Thepot S, Hunault M, Guillerm G, Berthou C, Ugo V, Lippert É, Ianotto JC.

Leuk Lymphoma. 2018 Apr 4:1-9. doi: 10.1080/10428194.2018.1441408. [Epub ahead of print]

PMID:
29616837
2.

Extended diversity analysis of cultivated grapevine Vitis vinifera with 10K genome-wide SNPs.

Laucou V, Launay A, Bacilieri R, Lacombe T, Adam-Blondon AF, Bérard A, Chauveau A, de Andrés MT, Hausmann L, Ibáñez J, Le Paslier MC, Maghradze D, Martinez-Zapater JM, Maul E, Ponnaiah M, Töpfer R, Péros JP, Boursiquot JM.

PLoS One. 2018 Feb 8;13(2):e0192540. doi: 10.1371/journal.pone.0192540. eCollection 2018.

3.

Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study.

Mansier O, Luque Paz D, Ianotto JC, Le Bris Y, Chauveau A, Boyer F, Conejero C, Fitoussi O, Riou J, Adiko D, Touati M, Chauzeix J, Viallard JF, Béné MC, Giraudier S, Ugo V, Lippert E.

Am J Hematol. 2018 Aug;93(4):E84-E86. doi: 10.1002/ajh.25014. Epub 2018 Jan 12. No abstract available.

PMID:
29266414
4.

Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study.

Ianotto JC, Chauveau A, Boyer-Perrard F, Gyan E, Laribi K, Cony-Makhoul P, Demory JL, de Renzis B, Dosquet C, Rey J, Roy L, Dupriez B, Knoops L, Legros L, Malou M, Hutin P, Ranta D, Benbrahim O, Ugo V, Lippert E, Kiladjian JJ.

Haematologica. 2018 Mar;103(3):438-446. doi: 10.3324/haematol.2017.181297. Epub 2017 Dec 7.

5.

Incidence and impact of atrial arrhythmias on thrombotic events in MPNs.

Mahé K, Delluc A, Chauveau A, Castellant P, Mottier D, Dalbies F, Berthou C, Guillerm G, Lippert E, Ianotto JC.

Ann Hematol. 2018 Jan;97(1):101-107. doi: 10.1007/s00277-017-3164-x. Epub 2017 Nov 21.

PMID:
29164292
6.

A new version of the grapevine reference genome assembly (12X.v2) and of its annotation (VCost.v3).

Canaguier A, Grimplet J, Di Gaspero G, Scalabrin S, Duchêne E, Choisne N, Mohellibi N, Guichard C, Rombauts S, Le Clainche I, Bérard A, Chauveau A, Bounon R, Rustenholz C, Morgante M, Le Paslier MC, Brunel D, Adam-Blondon AF.

Genom Data. 2017 Sep 18;14:56-62. doi: 10.1016/j.gdata.2017.09.002. eCollection 2017 Dec. No abstract available.

7.

Acute myeloid leukaemia (FAB AML-M4Eo) with cryptic insertion of cbfb resulting in cbfb-Myh11 fusion.

Douet-Guilbert N, Chauveau A, Gueganic N, Guillerm G, Tous C, Le Bris MJ, Basinko A, Morel F, Ugo V, De Braekeleer M.

Hematol Oncol. 2017 Sep;35(3):385-389. doi: 10.1002/hon.2268. Epub 2015 Nov 2. Review.

PMID:
28906004
8.

Skin prick tests and specific IgE in 10-year-old children: Agreement and association with allergic diseases.

Chauveau A, Dalphin ML, Mauny F, Kaulek V, Schmausser-Hechfellner E, Renz H, Riedler J, Pekkanen J, Karvonen AM, Lauener R, Roduit C, Vuitton DA, von Mutius E, Dalphin JC; PASTURE Study Group.

Allergy. 2017 Sep;72(9):1365-1373. doi: 10.1111/all.13148. Epub 2017 Apr 12.

PMID:
28235151
9.

[Food protein-induced enterocolitis syndrome (FPIES) in 14 children].

Delahaye C, Chauveau A, Kiefer S, Dumond P.

Arch Pediatr. 2017 Apr;24(4):310-316. doi: 10.1016/j.arcped.2017.01.011. Epub 2017 Feb 21. French.

PMID:
28233719
10.

[Pre-mRNA splicing: when the spliceosome loses ground].

Dujardin G, Daguenet É, Bernard DG, Flodrops M, Durand S, Chauveau A, El Khoury F, Le Jossic-Corcos C, Corcos L.

Med Sci (Paris). 2016 Dec;32(12):1103-1110. doi: 10.1051/medsci/20163212014. Epub 2017 Jan 3. Review. French.

11.

Sequential analysis of 18 genes in polycythemia vera and essential thrombocythemia reveals an association between mutational status and clinical outcome.

Luque Paz D, Chauveau A, Boyer F, Buors C, Samaison L, Cottin L, Seegers V, Férec C, Le Maréchal C, Gueguen P, Lippert E, Ianotto JC, Ugo V.

Genes Chromosomes Cancer. 2017 May;56(5):354-362. doi: 10.1002/gcc.22437. Epub 2017 Feb 1.

PMID:
27997717
12.

JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort.

Ianotto JC, Chauveau A, Mottier D, Ugo V, Berthou C, Lippert E, Delluc A.

Ann Hematol. 2017 Mar;96(3):383-386. doi: 10.1007/s00277-016-2853-1. Epub 2016 Oct 20.

PMID:
27766390
13.

Absence of CALR mutations in JAK2-negative polycythemia.

Chauveau A, Nibourel O, Tondeur S, Paz DL, Mansier O, Paul F, Wemeau M, Preudhomme C, Lippert E, Ugo V; French Intergroup of Myeloproliferative Neoplasms.

Haematologica. 2017 Jan;102(1):e15-e16. doi: 10.3324/haematol.2016.154799. Epub 2016 Oct 6. No abstract available.

14.

Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study.

Orvain C, Luque Paz D, Dobo I, Cottin L, Le Calvez G, Chauveau A, Mercier M, Farhi J, Boyer F, Ianotto JC, Guibourg B, Rousselet MC, Zandecki M, Ifrah N, Hunault-Berger M, Ugo V, Genevieve F.

Ann Hematol. 2016 Oct;95(11):1819-23. doi: 10.1007/s00277-016-2784-x. Epub 2016 Sep 1.

PMID:
27582015
15.

Disagreement between Skin Prick Tests and Specific IgE in Early Childhood.

Chauveau A, Dalphin ML, Kaulek V, Roduit C, Pugin A, von Mutius E, Vuitton DA, Dalphin JC.

Int Arch Allergy Immunol. 2016;170(2):69-74. doi: 10.1159/000446776. Epub 2016 Jul 26.

16.

Immediate hypersensitivity to extensively hydrolyzed formulas: An important reminder.

Chauveau A, Nguyen-Grosjean VM, Jacquenet S, Richard C, Mouton-Faivre C.

Pediatr Allergy Immunol. 2016 Aug;27(5):541-3. doi: 10.1111/pai.12556. Epub 2016 Apr 14. No abstract available.

PMID:
26919025
17.

Extinction of myeloproliferative neoplasm by acquisition of a lymphoid disease: JAK2 (V617F) and JAK2 exon 12 allele burden disappearance during the follow-up of two patients.

Mahé K, Luque Paz D, Couturier MA, Chauveau A, Quintin-Roué I, Berthou C, Ugo V, Lippert E, Ianotto JC.

Ann Hematol. 2016 Feb;95(3):529-31. doi: 10.1007/s00277-015-2559-9. Epub 2015 Nov 27. No abstract available.

PMID:
26611851
18.

Development of two major resources for pea genomics: the GenoPea 13.2K SNP Array and a high-density, high-resolution consensus genetic map.

Tayeh N, Aluome C, Falque M, Jacquin F, Klein A, Chauveau A, Bérard A, Houtin H, Rond C, Kreplak J, Boucherot K, Martin C, Baranger A, Pilet-Nayel ML, Warkentin TD, Brunel D, Marget P, Le Paslier MC, Aubert G, Burstin J.

Plant J. 2015 Dec;84(6):1257-73. doi: 10.1111/tpj.13070.

19.

Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.

Verger E, Cassinat B, Chauveau A, Dosquet C, Giraudier S, Schlageter MH, Ianotto JC, Yassin MA, Al-Dewik N, Carillo S, Legouffe E, Ugo V, Chomienne C, Kiladjian JJ.

Blood. 2015 Dec 10;126(24):2585-91. doi: 10.1182/blood-2015-07-659060. Epub 2015 Oct 20.

20.

Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib.

Luque Paz D, Ianotto JC, Chauveau A, Guibourg B, Lecucq L, Lippert E, Ugo V.

Ann Hematol. 2016 Jan;95(2):349-50. doi: 10.1007/s00277-015-2518-5. Epub 2015 Oct 13. No abstract available.

PMID:
26459144

Supplemental Content

Loading ...
Support Center